Skip to content

Nasdaq · CIK 0001867066

DERM Journey Medical Corp

Insider trading from SEC Form 4. Last filing Aug 26, 2025. Close $6.31 on Oct 9, 2026, +44% from the 52-week low and -32% from the high.

Last 90 days

Net insider value
$0
no open-market trades
Buys
0
$0 by 0 insiders
Sells
0
$0 by 0 insiders
Insiders on file
8
with a Form 4 at this company

Price and insider trades, last year

DERMOct 9, 2026 · close 6.31

Daily candles, adjusted for splits and dividends. Green arrows are insider buys, red are sells, sized by value. Click a marked bar to open the signal.Charts by TradingView Lightweight Charts™

Signals

Open-market buys and sells at Journey Medical Corp, scored.

ScoreInsiderValueHoldingsPrice contextFiled
35WeakRamsey Alloush
COO
sell
$20k
2,857 shares
-1%+92% from low-7% from high
37WeakJoseph Benesch
CFO
sell
$16k
2,409 shares
-1%+92% from low-7% from high
46ModerateClaude Maraoui
President & CEO
sell
$33k
4,834 shares
-0%+92% from low-7% from high
38WeakClaude Maraoui
President & CEO
sell
$247k
49,271 shares
-2%-
45ModerateClaude Maraoui
President & CEO
sell
$203k
40,456 shares
-2%-
48ModerateClaude Maraoui
President & CEO
sell
$361k
70,556 shares
-3%-
30WeakJoseph Benesch
CFO
sell
$7,084
1,365 shares
-3%-

Transactions

The last 33 rows filed, every code.

DateInsiderTransactionSharesPriceValueHoldings afterFiled
Aug 25, 2025Claude Maraoui
President & CEO
MOption exercise
Common Stock, $0.0001 par value
+1,250,000$0.07$81k2,397,590Aug 26, 2025
Aug 25, 2025Claude Maraoui
President & CEO
FTax withholding
Common Stock, $0.0001 par value
-10,877$7.47$81k2,386,713Aug 26, 2025
Aug 25, 2025Claude Maraoui
President & CEO
MOption exercise
Stock Option (Right to Buy)derivative
-1,250,000$0.00$00Aug 26, 2025
Aug 5, 2025Neil Herskowitz
director
AGrant or award
Common Stock, $0.0001 par value
+20,000$0.00$0108,618Aug 7, 2025
Aug 5, 2025Michael Cooper Pearce
director
AGrant or award
Common Stock, $0.0001 par value
+20,000$0.00$057,173Aug 7, 2025
Aug 5, 2025Miranda Jayne Toledano
director
AGrant or award
Common Stock, $0.0001 par value
+20,000$0.00$0108,618Aug 7, 2025
Aug 5, 2025Justin Adam Smith
director
AGrant or award
Common Stock, $0.0001 par value
+20,000$0.00$0171,618Aug 7, 2025
Aug 5, 2025Lindsay A Rosenwald Md
director
AGrant or award
Common Stock, $0.0001 par value
+50,000$0.00$0211,146Aug 7, 2025
Jun 25, 2025Justin Adam Smith
director
AGrant or award
Common Stock, $0.0001 par value
+7,173$0.00$0151,618Jul 7, 2025
Jun 25, 2025Miranda Jayne Toledano
director
AGrant or award
Common Stock, $0.0001 par value
+7,173$0.00$088,618Jul 7, 2025
Jun 25, 2025Lindsay A Rosenwald Md
director
AGrant or award
Common Stock, $0.0001 par value
+7,173$0.00$0161,146Jul 7, 2025
Jun 25, 2025Michael Cooper Pearce
director
AGrant or award
Common Stock, $0.0001 par value
+7,173$0.00$037,173Jul 7, 2025
Jun 25, 2025Neil Herskowitz
director
AGrant or award
Common Stock, $0.0001 par value
+7,173$0.00$088,618Jul 7, 2025
Jun 17, 2025Ramsey Alloush
Chief Operating Officer
AGrant or award
Common Stock, $0.0001 par value
+46,863$0.00$0551,680Jun 20, 2025
Jun 17, 2025Joseph Benesch
CFO
AGrant or award
Common Stock, $0.0001 par value
+28,907$0.00$0232,464Jun 20, 2025
Jun 17, 2025Claude Maraoui
President & CEO
AGrant or award
Common Stock, $0.0001 par value
+49,277$0.00$02,397,590Jun 20, 2025
Jun 17, 2025Joseph Benesch
CFO
AGrant or award
Stock Option (Right to Buy)derivative
+41,860$0.00$041,860Jun 20, 2025
Jun 17, 2025Claude Maraoui
President & CEO
AGrant or award
Stock Option (Right to Buy)derivative
+82,915$0.00$082,915Jun 20, 2025
Jun 17, 2025Ramsey Alloush
Chief Operating Officer
AGrant or award
Stock Option (Right to Buy)derivative
+62,795$0.00$062,795Jun 20, 2025
May 2, 2025Ramsey Alloush
COO
SOpen-market sale
Common Stock, $0.0001 par value
-2,857$6.84$20k504,817May 5, 2025
May 2, 2025Joseph Benesch
CFO
SOpen-market sale
Common Stock, $0.0001 par value
-2,409$6.84$16k203,557May 5, 2025
May 2, 2025Claude Maraoui
President & CEO
SOpen-market sale
Common Stock, $0.0001 par value
-4,834$6.84$33k2,348,313May 5, 2025
Jan 3, 2024Joseph Benesch
CFO
AGrant or award
Common Stock, $0.0001 par value
+80,000$0.00$0125,966Apr 16, 2025
Jan 3, 2024Claude Maraoui
President & CEO
AGrant or award
Common Stock, $0.0001 par value
+175,000$0.00$02,178,147Apr 16, 2025
May 1, 2024Joseph Benesch
CFO
AGrant or award
Common Stock, $0.0001 par value
+80,000$0.00$0205,966Apr 16, 2025
May 1, 2024Claude Maraoui
President & CEO
AGrant or award
Common Stock, $0.0001 par value
+175,000$0.00$02,353,147Apr 16, 2025
Mar 11, 2025Claude Maraoui
President & CEO
SOpen-market sale
Common Stock, $0.0001 par value
-49,271$5.01$247k2,003,147Mar 11, 2025
Mar 6, 2025Claude Maraoui
President & CEO
SOpen-market sale
Common Stock, $0.0001 par value
-25,551$5.04$129k2,067,323Mar 10, 2025
Mar 7, 2025Claude Maraoui
President & CEO
SOpen-market sale
Common Stock, $0.0001 par value
-14,905$5.01$75k2,052,418Mar 10, 2025
Mar 3, 2025Claude Maraoui
President & CEO
SOpen-market sale
Common Stock, $0.0001 par value
-23,508$5.19$122k2,139,922Mar 5, 2025
Mar 4, 2025Claude Maraoui
President & CEO
SOpen-market sale
Common Stock, $0.0001 par value
-28,901$5.04$146k2,111,021Mar 5, 2025
Mar 5, 2025Claude Maraoui
President & CEO
SOpen-market sale
Common Stock, $0.0001 par value
-18,147$5.13$93k2,092,874Mar 5, 2025
Feb 21, 2025Joseph Benesch
CFO
SOpen-market sale
Common Stock, $0.0001 par value
-1,365$5.19$7,08445,966Feb 24, 2025

Insiders

Everyone who has filed a Form 4 here.

Not investment advice. Scores and forward returns are decision support built from public SEC filings and past prices; they describe what happened after comparable filings, not what will happen after this one. Do your own research and size your risk.

DERM insider trading: Journey Medical Corp | InsiderTell